Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A02522 | Pages: NA | Charts: NA | Tables: NA |
Automated defibrillators are devices that automatically analyze the heart rhythm and incase of any problem detected it responds by delivering an electric shock to restore a normal heart rhythm. It has a small size and is easy to use, due to which AEDs are installed in many settings (such as hospitals and airports), and play a key role in expanding the number of opportunities for life-saving defibrillation.
The technological advancements in automated defibrillators, rise in prevalence in cardiovascular diseases, and rapid growth in the aging population t are the major factors that drive the market growth. In addition, growth in focus to provide public access defibrillators also fuel the market growth. In contrast, increase in pricing pressure on market players restraint the market growth. However, emerging markets make way for growth opportunities for the market.
This report segments the automated defibrillator market based on product, end user, and region. Based on product, it is bifurcated into semi-automated external defibrillators and fully automated external defibrillator. In terms of end user, it is divided into hospitals, clinics, & cardiac centers, pre-hospitals, public access markets, home care and alternate care markets. Based on geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the leading manufacturing companies included in the report are Medtronic PLC, St. Jude Medical, Inc. (Abbott laboratories), Boston Scientific Corporation, Koninklijke Philips N.V., Zoll Medical Corporation (Asahi Kasei Corporation), Biotronik Se & Co.Kg, Physio-Control International, Inc., Cardiac Science Corporation (Aurora Capital Group), Sorin Group (Now Livanova PLC), and Nihon Kohden Corporation.
Key Benefits
Key Market Segments
Key Market Players